Back to Trades
REED JOHN C
DirectorCIK 0001181561
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 2
- Active
- 2025–2026
REED JOHN C, Director, has filed 6 SEC reports (2025–2026), spread across 2 companies, totaling $58.8M in disclosed volume. Weighing $0 bought versus $20.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Aug 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | REED JOHN C | Director | Grant | $547.1K |
| Aug 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | REED JOHN C | Director | Other | $0 |
| May 4 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Exercise | $2.5M |
| Feb 18 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $13.1M |
| Oct 20 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $4.2M |
| Jul 18 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $3.1M |
6 filings